Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


Last $34.14 USD
Change Today -0.32 / -0.93%
Volume 271.7K
MASI On Other Exchanges
Symbol
Exchange
Berlin
NASDAQ GS
As of 8:10 PM 04/17/15 All times are local (Market data is delayed by at least 15 minutes).

masimo corp (MASI) Snapshot

Open
$34.08
Previous Close
$34.46
Day High
$34.55
Day Low
$34.02
52 Week High
04/14/15 - $35.13
52 Week Low
08/8/14 - $19.30
Market Cap
1.8B
Average Volume 10 Days
398.4K
EPS TTM
$1.18
Shares Outstanding
52.6M
EX-Date
11/23/12
P/E TM
28.9x
Dividend
--
Dividend Yield
--
Current Stock Chart for MASIMO CORP (MASI)

masimo corp (MASI) Related Businessweek News

No Related Businessweek News Found

masimo corp (MASI) Details

Masimo Corporation, a medical technology company, develops, manufactures, and markets noninvasive monitoring technologies worldwide. It offers Masimo Signal Extraction Technology (SET) with measure-through-motion and low-perfusion pulse oximetry monitoring to address the primary limitations of conventional pulse oximetry. The company also provides Masimo rainbow SET Platform, which includes rainbow SET Pulse CO-Oximetry products that noninvasively monitor multiple blood-based measurements, including oxygen saturation, pulse rate, perfusion index, pleth variability index, and respiration rate from pleth; noninvasively monitor hemoglobin, carboxyhemoglobin, and methemoglobin; monitor arterial oxygen saturation; and calculates oxygen content and oxygen reserve index. In addition, it offers SedLine brain function monitoring technology that measures the brain’s electrical activity by detecting EEG signals; capnography and gas monitoring products, such as external plug-in-and-measure capnography and gas analyzers, integrated modules, and handheld capnograph and capnometer devices; O3 regional oximetry for tissue oxygen saturation measurement; SafetyNet, a patient surveillance, remote monitoring, and clinician notification solution; and Halo Index, an indicator that facilitates trending and assessment of physiological measurements. Further, the company offers remote alarm/monitoring solutions, software, and connectivity solutions. The company’s patient monitoring technologies incorporate a monitor or circuit board and sensors, including proprietary single-patient use, reusable and rainbow ReSposable sensors, and patient cables. Masimo Corporation provides its products directly, as well as through distributors and original equipment manufacturers partners to hospitals, emergency medical service providers, physician offices, veterinarians, long term care facilities, and consumers. The company was founded in 1989 and is headquartered in Irvine, California.

1,200 Employees
Last Reported Date: 02/17/15
Founded in 1989

masimo corp (MASI) Top Compensated Officers

Founder, Chairman and Chief Executive Officer
Total Annual Compensation: $712.5K
Chief Financial Officer, Executive Vice Presi...
Total Annual Compensation: $334.4K
President of Worldwide OEM Business & Blood M...
Total Annual Compensation: $335.7K
President of Worldwide Sales, Professional Se...
Total Annual Compensation: $332.4K
Chief Information Officer and Executive Vice ...
Total Annual Compensation: $329.2K
Compensation as of Fiscal Year 2013.

masimo corp (MASI) Key Developments

Masimo Corporation Unveils New Patient Monitoring Systems

Masimo Corporation has unveiled Patient SafetyNet Series 5000 along with Iris Connectivity and MyView through the Root patient monitoring and connectivity platform. This series of Patient SafetyNet offers a new level of interoperability designed to enhance clinician workflows, and reduce the cost of care, from operating rooms to medical-surgical units. Today's medical-surgical units utilize intermittent vital signs spot checks, standalone monitoring systems, and a host of disparate legacy devices, which become isolated stores of valuable patient data. Existing approaches for device interoperability typically require separate hardware, software, and/or network infrastructure, which can clutter the patient room, increase complexity, burden IT management, and increase costs. Masimo's Patient SafetyNet Series 5000 with Iris enables Root to intake data from all devices connected to the patient, acting as an in-room patient monitor and connectivity hub. Alarms and alerts for all devices are seamlessly forwarded to the patient's clinician and all device data are effortlessly documented in the patient's electronic medical record (EMR). The patient-centric user interface of Patient SafetyNet Series 5000 displays near real-time data from all devices, providing a single unified dashboard of patient information. Having such a holistic view can enable caregivers to more quickly assess patient status allowing for faster clinical decisions. To simplify documentation of patient data, Root enables clinicians to easily verify and send patient vitals, as well as all connected medical device information data to the EMR directly from Root. Data can also be sent to the EMR periodically. An interface between the Patient SafetyNet Series 5000 Appliance and the hospital ADT system allows clinicians to receive ADT information on Root for positive patient identification at the bedside. Clinicians can also manually enter additional data on the Root device, including temperature, blood pressure, level of consciousness, pain score, and urine output. MyView is a wireless, presence-detection system that enables clinicians to automatically display customized clinical profiles on Masimo devices, such as Root, Radical-7, and the Patient SafetyNet View Station. When a clinician approaches the device, a clinician-worn MyView badge signals the device to display a preselected set of parameters and waveforms tailored to the individual clinician's preferences. MyView allows clinicians the ability to consume medical device information in a manner that is most conducive to optimizing their workflow, while the presence mapping data collected by all the Masimo devices can provide information on how clinicians spend time with their patients. This allows nursing leadership and management the opportunity to examine analytical data on patient and clinician interactions to optimize workflows across the unit, hospital, or hospital system.

Penn Highlands Selects SedLine Brain Function Monitoring from Masimo Corporation

Penn Highlands DuBois has selected SedLine brain function monitoring through the Root patient monitoring and display platform from Masimo Corporation to monitor patients under anesthesia or sedation. Penn Highlands DuBois had been using Bispectral Index (BISTM) technology from Covidien. Root offers Masimo's SedLine brain function monitoring, which provides four channels of EEG to help clinicians better understand the effects of anesthesia on the brain. SedLine measures the effects of anesthesia and sedation by monitoring both sides of the brain's electrical activity. As such, SedLine provides a wealth of EEG-based data, which can help clinicians monitor anesthesia.

Masimo Announces New Clinical Study on Oxygen Reserve Index(TM) or ORI(TM)

Masimo announced that a new clinical study presented at the International Anesthesia Research Society's 2015 Annual Meeting showed that Masimo's latest noninvasive patient monitoring parameter, Oxygen Reserve Index(TM) or ORI(TM), could help clinicians in the early detection of an impending desaturation in patients receiving supplemental oxygen. Pulse oximetry (SpO2) provides noninvasive and continuous visibility to arterial blood oxygenation in hypoxia and normoxia (normal oxygenation). Clinicians often use arterial oxygen partial pressure (PaO2), which can be intermittent and delayed, to monitor levels of hyperoxia (higher than normal oxygenation). Between invasive sampling, changes in PaO2 can be difficult to assess, and therefore hypoxia or hyperoxia can occur unexpectedly. ORI, Masimo's 11th rainbow(r) parameter2, is a relative index of the partial pressure of oxygen in arterial blood (PaO2) in the range of 100 to 200 mmHg. ORI is intended to supplement, not replace, SpO2 monitoring and PaO2 measurements.

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
MASI:US $34.14 USD -0.32

MASI Competitors

Market data is delayed at least 15 minutes.

Company Last Change
CONMED Corp $48.29 USD -0.27
Cyberonics Inc $63.11 USD -1.48
Integra LifeSciences Holdings Corp $59.87 USD -1.26
NuVasive Inc $41.55 USD -1.18
Thoratec Corp $42.87 USD -0.97
View Industry Companies
 

Industry Analysis

MASI

Industry Average

Valuation MASI Industry Range
Price/Earnings 26.2x
Price/Sales 3.1x
Price/Book 5.9x
Price/Cash Flow 24.8x
TEV/Sales 2.6x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact MASIMO CORP, please visit www.masimo.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.